• FirefoxInstall the new Firefox »
  •  Dow Down 0.68% Nasdaq Down 0.32%

    AbbVie Inc. (ABBV)

    -NYSE
    60.27 Up 0.65(1.09%) 2:11PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:59.62
    Open:59.32
    Bid:60.20 x 800
    Ask:60.21 x 100
    1y Target Est:68.64
    Beta:1.66
    Earnings Date:Apr 23 - Apr 27 (Est.)
    Day's Range:59.03 - 60.37
    52wk Range:45.50 - 70.76
    Volume:5,603,566
    Avg Vol (3m):9,678,440
    Market Cap:96.06B
    P/E (ttm):54.79
    EPS (ttm):1.10
    Div & Yield:2.04 (3.40%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVUp 1.09%96.06B
    MRKUp 0.07%165.69B
    NVSUp 0.07%237.78B
    PFEUp 0.29%212.43B

    Key Statistics

    Forward P/E (1 yr):12.04
    P/S (ttm):4.76
    Ex-Dividend Date:13-Apr-15

    Analysts

    Annual EPS Est (Dec-15) :4.39
    Quarterly EPS Est (Mar-15) :0.85
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):0.88

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback